Navigation Links
Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
Date:7/24/2008

New JIT Enrollment Program Speeds Oncology Patient Accrual

DENVER, July 24 /PRNewswire/ -- Pharmatech, Inc., a Research Management Organization (RMO), has contracted with five leading pharmaceutical companies to provide research and site management services for their clinical trials using the Just-in-Time (JIT) enrollment strategy. The new trials include the following disease indications: follicular Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, Metastatic Sarcoma, Chronic Myelogenous Leukemia, and Non-Small Cell Lung Cancer (NSCLC).

Pharmatech will manage the trials using its innovative JIT approach. This streamlined approach was created to increase enrollment in oncology clinical trials. This patient first initiative allows for identification of cancer patients through basic standard of care procedures, so the site opens only if the patient qualifies for the study. Patient enrollment increases because a protocol is rolled out to a large number of qualified Research Network sites with minimal expense of time and capital for both the sites and sponsors.

The new oncology clinical trials are targeted to achieve enrollment of over 500 cancer patients with the participation of approximately 165 Pharmatech Research Network sites. Matthew Wiener, Pharmatech CEO, states that "The recent activity in new business has been a true testament to the acceptance of the Just-In-Time enrollment strategy. Study sponsors and sites have praised the new enrollment methodology, as cancer patients are treated in a more efficient manner and sponsors see their trials completed in a shorter time frame."

About Pharmatech, Inc.:

Pharmatech, headquartered in Denver, Colorado, is a Research Management Organization (RMO) dedicated to the highest quality of clinical research. Pharmatech provides services of a Site Management Organization (SMO) and a Contract Research Organization (CRO) with a focus in oncology clinical trials. Through an organized
'/>"/>

SOURCE Pharmatech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
2. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
3. Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders
4. VIRxSYS to Host a Web Conference to Announce Clinical Trial Update
5. New AAHC Toolkit Available to Optimize Clinical Research Administration
6. Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
7. Wacker Validates Scalability of Anticalin(R) Production With E.coli Secretion Technology and Will Produce Pieris First Clinical Candidate PRS-050
8. Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis
9. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
10. BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
11. AFFiRiS: Milestone Reached in Clinical Trial of Alzheimers Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2008)...om awareness can improve recovery , , Audio...re available on the Mayo Clinic News Blog. Please ..., , ROCHESTER, Minn., Nov. 25 /PRNewswire-US...of stroke patients don,t think they,re having a st... until their condition worsens. The findings appea...
(Date:11/25/2008)...VALE, Calif., Nov. 25 Ph...ed that the company has completed a Phase 1,clini...st-in-class,small-molecule Factor VIIa inhibitor....volunteers to evaluate the safety and pharmacologi... PCI-27483 resulted in a linear dose,response in ...
(Date:11/24/2008)...WORTH, N.J., Nov. 24 Lea... today provided an update for investors on the com...innovative portfolio that includes 46 new entities... 29 in preclinical studies. , , "Research a...chering-Plough as we continue our transformation,"...
(Date:11/24/2008)...TO, Nov. 24 /PRNewswire-FirstCall/ - Predictive me...ay announced that it has entered into a fully fund...rld,s largest cosmetic companies. PreMD,s PREVU* s...ith one of the cosmetic company,s skin care produc...arlier successful study completed by PreMD with th...
Breaking Medicine Technology:Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5PreMD Inc. Enters Clinical Study with Cosmetics Conglomerate 2FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function 348 1FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function 348 2FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function 348 3FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function 348 4ADHD Drugs Help Boost Childrens Grades 1741 1ADHD Drugs Help Boost Childrens Grades 1741 2ADHD Drugs Help Boost Childrens Grades 1741 3Radiation therapy technique reduces length of prostate cancer treatment 1736 1Radiation therapy technique reduces length of prostate cancer treatment 1736 2Radiation therapy technique reduces length of prostate cancer treatment 1736 3Vet school in 26 23163 3B10 7 million initiative to boost veterinary research training 1731 1Vet school in 26 23163 3B10 7 million initiative to boost veterinary research training 1731 2Vet school in 26 23163 3B10 7 million initiative to boost veterinary research training 1731 3
...h (OMX Nordic: ACTI) presented,pre-clinical result...ropean League Against Rheumatism, <a target="_blan...conference, June,13-16*. , "The new pre-clinical d...ibitory effect on disease development in an,experi...nted Sven,Andréasson, President & CEO A...
... Percent Fewer RA Patients,Reported Job Loss When ...o Methotrexate Alone, BARCELONA, Spain, June 15, 2... (RA) is one of the most common causes of,disabili...how that,rheumatoid arthritis (RA) patients treate...ing longer, had fewer absences and reported,greate...
Other Medicine Technology:New Positive Pre-clinical Data for Active Biotech's RA Project I-3D 2Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 2Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 3Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 4Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 5Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 6Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 7
(Date:12/1/2008)...ency,s goals, commitment and resources , ... to criticism that it has done a poor job safeguar...rug Administration released a report Monday detail...he most important changes in 2008 was the agency,s...te and local health departments to protect the foo...
(Date:12/1/2008)... Cancer Institute,s cancer registry has found that...ayed or incomplete radiation treatment following b... care can lead to worse outcomes. , Dr. Heather ...olleagues found that among a nationally representa... patients aged 65 and older, almost 1,300 women ex...
(Date:12/1/2008)...wswire/ -- Due to the urgent need to disseminate a...research and clinical care, publisher Mary Ann L...s to all archival online issues of the company,s A...of World AIDS Day. Free online access is available...ub.com/apc ) and AIDS Research and Human Retrovi...
(Date:12/1/2008)...SNewswire/ -- Americans United for Life (AUL) to...tive resolution opposing the federal "Freedom of C...o adopt the resolution immediately when they conve...oest, AUL President & CEO said, "The so-called... It protects and promotes the abortion industry, ...
Breaking Medicine News(10 mins):Health News:FDA Touts Efforts to Enhance Food Safety 2Health News:FDA Touts Efforts to Enhance Food Safety 3Health News:FDA Touts Efforts to Enhance Food Safety 4Health News:Delays in radiation therapy lead to increased breast cancer recurrence 2Health News:Mary Ann Liebert, Inc. Provides Free Online Journal Access in Recognition of World AIDS Day 2Health News:Americans United for Life Urges State Legislatures to Oppose Federal Power Grab: Provides Model Resolution Denouncing Freedom of Choice Act (FOCA) 2
...s the recommendation by the American Heart Associa...ble fiber,// is beneficial to your heart. A number...y fiber intake and the reduction of heart disease....sed on the relationship of total and soluble dieta...
...ent that hormone replacement therapy is associated...t cancer,// many postmenopausal women have been l...nt. Doctors say the hardest group to treat right ... first facing menopause. These women are likely to...
...m back pain, pelvic pressure, frequent urination o...lame. Fibroids are non-cancerous // growths found ...l to the size of a cantaloupe or larger. Now, ther...bolization -- a treatment that’s becoming the proc...
...a diet that consists of healthy foods, including a...l as certain drugs. Researchers say incorporating...ly lower cholesterol levels. The easiest substitut...onds instead of popcorn, pretzels or potato chips....
Other Medicine News:Health News:High Fiber Diet Found To Protect The Heart 2
Since 1991 Intersurgical Incorporated manufactures high efficiency breathing filters, heat and moisture exchangers, ventilator circuits, oxygen therapy products, hand-held nebulizers and an extensive
Since 1991 Intersurgical Incorporated manufactures high efficiency breathing filters, heat and moisture exchangers, ventilator circuits, oxygen therapy products, hand-held nebulizers and an extensive
...Ulti-Mist™ HME product line has the right pr...dults and from intubated patients to patients with...dification for both anesthesia and critical care a...provide maximum protection for patients and staff ...
...e hygroscopic condenser humidifiers (HCH) capture ... them in the inspired gas. Small and compact, they...nd hygroscopic benefits. Depending on the tidal vo...l-volume model., ,The adult HCH is ideal for pati...
Medicine Products: